Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia
International Immunopharmacology (2021) - Comments
pubmed: 33735712  doi: 10.1016/j.intimp.2021.107522  issn: 1567-5769  issn: 1878-1705 

Masoud Solaymani-Dodaran, Mostafa Ghanei, Mehdi Bagheri, Ali Qazvini, Ensieh Vahedi, Seyed Hassan Saadat, Seyed Amin Setarehdan, Akram Ansarifar, Hossein Biganeh, Arash Mohazzab, Davood Khalili, Amir Hosein Ghazale, Mohammad Reza Heidari, Ali Taheri, Maliheh Khoramdad, Mohammad Mahdi Asadi, Masoud Nazemieh, Mojtaba Varshochi, Samaneh Abbasian, Ali Bakhtiari